Episode 2: Within the Next 10 Years, Will Traditional Clinical Trials be Obsolete?
In this episode, host Nicola Hill explores the hypothesis that fully virtualised decentralized clinical trials (DCT), that operate invisibly, will make traditional models obsolete within the next decade.
Joining her are Craig Lipset, Co-Chair of the Decentralized Trials and Research Alliance, and…
The Digital Evolution of DTRA
2026-05-29 DTRA is entering a new chapter. In this special episode, Craig Lipset, Amir Kalali, and Jane Myles discuss the evolution of DTRA from the Decentralized Trials & Research Alliance to the Digital Trials & Research Alliance. Hear why the change reflects the needs of DTRA's membership, how d…
DTRA's Craig Lipset on Decentralized Trials and Accelerating Rare Disease Research
New technologies have always driven advances in clinical research, and that's still true today. The Covid pandemic rapidly accelerated the adoption of decentralized trials, powered by emerging health tech, but in less dramatic times, life sciences must find ways to ensure continued innovation.
As …
Project Loom: Can AI Orchestrate the Future of Clinical Trials?
2026-07-24 In this episode of TGIF-DTRA, hosts Jane Myles, Craig Lipset, and Dr. Amir Kalali are joined by Donna Parker and Christoph Hornick from Duke University's iCubed to explore Project Loom, an initiative testing how agentic AI can support clinical trial operations.
The conversation covers wh…
Decentralized Trials, Access, and Advancement with Craig Lipset
Join Craig Lipset, co-chair of the Decentralized Trials and Research Alliance and head of Innovation at the Buffalo Initiative, as we discuss decentralized trial methods and democratization of drug development. We cover access to knowledge, tools, and data widening the funnel for rare and ultra-rar…
The Empty Chair Is Not Enough: Craig Lipset on Putting Patients at the Center of Clinical Research
How lived experience, decentralized trials, nonprofit drug development, and AI could reshape the path from scientific discovery to the patient. Clinical research is built to answer extraordinarily complex scientific questions. But for the person deciding whether to participate in a trial, the quest…
Reflections from the Life Science Technology Forum in China: Scale, Speed, and Ambition
Our hosts, Dr. Amir Kalali, Craig Lipset, and Jane Myles were joined by Owen Muir (Radial) to share insights from Beijing from the Life Sciences Technology Forum earlier this year. Notes on what they saw, heard, and learned about the rapidly evolving life sciences landscape in China were shared.
Th…
Theranos Deception vs. Incrementalism’s Trap | Hypothesize That! (CRIMES AGAINST INNOVATION)
In the shadowy corridors of laboratories and the silent pages of medical journals, there lie tales that have seldom been told. Tales of ambition that flew too close to the sun, of genius that turned into folly, and of innovation that... well, wasn't quite so innovative. This is—Crimes Against Innov…
Within the Next 10 Years, Will Traditional Clinical Trials Be Obsolete? | Hypothesize That! (FULL)
Could the clinical trials of the future operate seamlessly in the background of our daily lives? In this episode, host Nicola Hill explores the hypothesis that fully virtualised decentralized clinical trials (DCT), that operate invisibly, will make traditional models obsolete within the next decade…
Clinical Trials Beyond Walls: Building Choice Into Clinical Research
2026-09-11 Hosts Craig Lipset and Jane Myles were joined by Becky Kottschade and Dr. Tufia Haddad from the Mayo Clinic to share the evolution of Clinical Trials Beyond Walls, Mayo Clinic’s program for bringing digital and decentralized capabilities into clinical research.
Building on Mayo’s experie…
موتور جستجوی پادکست
می توانید از وب سایت ما برای جستجوی پادکست های3,830,485و قسمت های196,626,502بر اساس افراد، مکان ها یا موضوعات استفاده کنید.
سرمایه‌گذاری روی دانش بیشترین بازده را دارد؛ پس پادکست گوش می‌دهم.
‐ Benjamin "Llamacorn" Franklin
ویرایش
از کمک شما برای بروز نگهداشتن پایگاهدادههای پادکست سپاسگزاریم
